NDAORALCAPSULEPriority Review
Approved
Jan 2021
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
Calcineurin Inhibitors
Pharmacologic Class:
Calcineurin Inhibitor Immunosuppressant
Clinical Trials (2)
LUPKYNIS Drug-use Results Survey
Started Sep 2025
400 enrolled
Lupus Nephritis
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
Started Apr 2022
229 enrolled
Lupus Nephritis
Loss of Exclusivity
LOE Date
Dec 7, 2037
143 months away
Patent Expiry
Dec 7, 2037
Exclusivity Expiry
Jan 22, 2026